Rossa Medico Sdn Bhd Selected as InterCure’s Exclusive Distributor in Malaysia

InterCure’s non-drug hypertension treatment device, RESPeRATE® to be available to Malaysians

Fort Lee, NJ, USA and Penang, Malaysia – November 21, 2005

InterCure, Inc. announced today that it has signed a definitive agreement with Rossa Medico Sdn Bhd to distribute RESPeRATE®; InterCure's breakthrough FDA-cleared medical device, in Malaysia. The exclusive agreement marks the company’s sixth marketing partnership in the Asia-Pacific region following Korea, Thailand, China, Australia and New-Zealand.

"This distribution agreement with Rossa Medico Sdn Bhd will enable the hundreds of thousands of Malaysians with high blood pressure to benefit from RESPeRATE, the first non-drug medical device clinically proven to reduce high blood pressure without side effects", said InterCure CEO, Erez Gavish. "Many companies were competing for the distribution rights in Malaysia, and we are pleased to have selected Rossa Medico Sdn Bhd as our partner in Malaysia. We are confident that the extraordinary appeal of RESPeRATE as a tool to lower blood pressure coupled with Rossa Medico’s compelling distribution strategy is a formula for success."

"We believe RESPeRATE is an innovative product, ideally suited to address the growing demand for clinically proven non-drug therapies, and to complement pharmacotherapies to treat hypertension in Malaysia", said Dr Lim, Chairman of Rossa Medico Sdn Bhd. "Rossa Medico is very pleased to introduce the only FDA-cleared and CE mark certified medical device for the adjunctive treatment of hypertension to Malaysian physicians, and we are confident that their patients will benefit from RESPeRATE", said Steven Kwok, the company’s Marketing Director.

RESPeRATE will be available in Malaysia by December 2005. For more information, please call 1-300-88-1628 (Toll Free) or visit www.resperate.com.my.

About InterCure Inc.

InterCure is a medical device company that creates and sells products that harness the therapeutic power of breathing for the treatment of hypertension, heart failure, respiratory diseases and other conditions. With seven successful clinical trials, RESPeRATE® became the only non-drug medical device indicated by the American Food and Drug Administration (FDA) for the adjunctive treatment of hypertension. RESPeRATE is now available in the US, Europe, Australia and many other countries.

About Rossa Medico

Rossa Medico Sdn Bhd specializes in innovative medical and biotechnology marketing, sales and distribution in Malaysia. The company’s corporate office is in Penang with sales/distribution representatives available throughout Malaysia.


Contact:
Tom Kirwan, InterCure Inc.
+1.201.720.7750 x 7136
tkirwan@intercure.com

H.S. Yim, Rossa Medico Sdn Bhd
+6012-375-8776
hsyim@rossamedico.com